These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2561721)

  • 21. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of immune response to Japanese encephalitis virus infection in mice: effect of cyclosporin A on the production of HI antibody and interferon].
    Kushimoto K
    Fukuoka Igaku Zasshi; 1993 Dec; 84(12):512-9. PubMed ID: 8307549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
    Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 27. IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection.
    Jones T
    Curr Opin Mol Ther; 2009 Feb; 11(1):90-6. PubMed ID: 19169964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ChimeriVax-JE. Acambis.
    Jones T
    Curr Opin Investig Drugs; 2003 Aug; 4(8):1019-22. PubMed ID: 14508887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.
    Saluzzo JF
    Adv Virus Res; 2003; 61():419-43. PubMed ID: 14714439
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
    Gowal D; Tahlan AK
    Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.
    Ferguson M; Kurane I; Wimalaratne O; Shin J; Wood D;
    Vaccine; 2007 Jul; 25(29):5233-43. PubMed ID: 17590244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012.
    Trent DW; Minor P; Jivapaisarnpong T; Shin J;
    Biologicals; 2013 Nov; 41(6):450-7. PubMed ID: 23891495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of the second generation Japanese encephalitis (JE) vaccine.
    Igarashi A
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):493-500. PubMed ID: 3217827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
    Tsai TF
    Vaccine; 2000 May; 18 Suppl 2():1-25. PubMed ID: 10821969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.